Mouse A6-positive hepatic oval cells derived from embryonic stem cells

Abstract

Oval cells have a potential to differentiate into a variety of cell lineages including hepatocytes and biliary epithelia. Several models have been established to activate the oval cells by incorporating a variety of toxins and carcinogens, alone or combined with surgical treatment. Those models are obviously not suitable for the study on human hepatic oval cells. It is necessary to establish a new and efficient model to study the human hepatic oval cells. In this study, the hepatocyte growth factor (HGF) and epidermal growth factor (EGF) were used to induce differentiation of mouse embryonic stem (ES) cells into hepatic oval cells. We first confirmed that hepatic oval cells derived from ES cells, which are bipotential, do exist during the course of mouse ES cells’ differentiation into hepatic parenchymal cells. RT-PCR and transmission electron microscopy were applied in this study. The ratio of Sca-1+/CD34+ cells sorted by FACS in the induction group was increased from day 4 and reached the maximum on the day 8, whereas that in the control group remained at a low level. The differentiation ratio of Sca-1+/CD34+ cells in the induction group was significantly higher than that in the control group. About 92.48% of the sorted Sca-1+/CD34+ cells on the day 8 were A6 positive. Highly purified A6+/Sca-1+/CD34+ hepatic oval cells derived from ES cells could be obtained by FACS. The differentiation ratio of hepatic oval cells in the induction group (up to 4.46%) was significantly higher than that in the control group. The number of hepatic oval cells could be increased significantly by HGF and EGF. The study also examined the ultrastructures of ES-derived hepatic oval cells’ membrane surface by atomic force microscopy. The ES-derived hepatic oval cells cultured and sorted by our protocols may be available for the future clinical application.

Keywords

hepatic oval cells / embryonic stem cells / cell differentiation

References

[1] MichalopoulosGK, DeFrancesMC. Liver regeneration. Science, 1997, 276(5309): 60-66

[2] EvartsRP, NagyR, MarsdenE, et al.. A precursor product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis, 1987, 8(11): 1737-1740

[3] EvartsRP, NakatsukasaH, MarsdenER, et al.. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res, 1990, 50(11): 3439-3444

[4] PreiseggerKH, FactorVM, FuchsbichlerA, et al.. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl- 1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest, 1999, 79(2): 103-109

[5] EvensMJ, KaufmanMH. Establishment in culture of pluripotent cells from mouse embryos. Nature, 1981, 292(5819): 154-156

[6] ChinzeiR, TanakaY, Shimizu-SaitoK, et al.. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology, 2002, 36(1): 22-29

[7] ChoiD, OhHJ, ChangUJ, et al.. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant, 2002, 11(4): 359-368

[8] HuAB, CaiJY, ZhengQC, et al.. High-ratio differentiation of embryonic stem cells into hepatocytes in vitro. Liver Int, 2004, 24(3): 237-245

[9] PetersenBE, GrossbardB, HatchH, et al.. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology, 2003, 37(3): 632-640

[10] ThomsonJA, Itskovitz-EldorJ, ShapiroSS, et al.. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282(11): 1145-1147

[11] GermainL, BlouinMJ, MarceauN. Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha-fetoprotein, albumin, and cell surface-exposed components. Cancer Res, 1988, 48(17): 4909-4918

[12] GoldingM, SarrafCE, LalaniEN, et al.. Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology, 1995, 22(4): 1243-1253

[13] EngelhardtNV, FactorVM, YasovaAK, et al.. Common antigens of mouse oval and biliary epithelial cells. Expression on newly formed hepatocytes. Differentiation, 1990, 45(1): 29-37

[14] CrosbyHA, HubscherSG, JoplinRE, et al.. Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology, 1998, 28(4): 980-985

[15] PanCJ, LeiKJ, ChenH, et al.. Ontogeny of the murine glucose-6-phosphatase system. Arch Biochem Biophys, 1998, 358(1): 17-24

[16] SchmidtC, BladtF, GoedeckeS, et al.. Scatter factor/ hepatocyte growth factor is essential for live development. Nature, 1995, 373(6516): 699-702

[17] UeharaY, MinowaO, MoriC, et al.. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature, 1995, 373(6516): 702-705

[18] IshikiY, OhnishiH, MutoY, et al.. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology, 1992, 16(5): 1227-1235

[19] KamiyaA, KinoshitaT, MiyajimaA. Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. FEBS Lett, 2001, 492(1–2): 90-94

[20] HuZ, EvartsRP, FujioK, et al.. Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Carcinogenesis, 1996, 17(5): 931-938

[21] ShiotaG, KunisadaT, OyamaK, et al.. In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats. FEBS Lett, 2000, 470(3): 325-330

[22] HeZP, TanWQ, TangYF, et al.. Differentiation of putative hepatic stem cells derived from adult rats into mature hepatocytes in the presence of epidermal growth factor and hepatocyte growth factor. Differentiation, 2003, 71(4–5): 281-290

[23] OkanoJ, ShiotaG, MatsumotoK, et al.. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun, 2003, 309(2): 298-304

[24] NagyP, BisgaardHC, Santoni-RugiuE, et al.. In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology, 1996, 23(1): 71-79

[25] UlrichB, CrosbyHA, PramilaR, et al.. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell. Hepatology, 1999, 30(1): 112-117

[26] OmoriN, OmoriM, EvartsRP, et al.. Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology, 1997, 26(3): 720-727

[27] PetersenBE, GoffJP, GreenbergerJS, et al.. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology, 1998, 27(2): 433-445

[28] PetersenBE, BowenWC, PatreneKD, et al.. Bone marrow as a potential source of hepatic oval cells. Science, 1999, 284(5417): 1168-1170

[29] LagasseE, ConnorsH, Al-DhalimyM, et al.. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med, 2000, 6(11): 1229-1234